Fig. 2. Structures of battacin analogues used for elucidating MICs against bacteria. 9 was the negative control and 2 was the lead compound. The remaining analogues were accessed through CLipPA using free thiols from cysteine 12 in C-series (12a–12f, blue) and from MPA 13 in M-series (13a–13f, red).